Labshake search
Citations for Stemcell Technologies :
1 - 50 of 117 citations for Palmitic acid U 13C16 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: ... Collagenase and Hyaluronidase (1650 U/550 U, Stemcell Technologies, 07912) and 4 μg of hydrocortisone (Sigma ...
-
bioRxiv - Cell Biology 2024Quote: ... and collagenase/hyaluronidase (1650 U/550 U, Stem Cell Technologies, 07912). Samples were incubated at 37°C with shaking for 1.5 h for the fetal tissue ...
-
bioRxiv - Developmental Biology 2021Quote: ... Retinoic acid (Stemcell Technologies) at 0.25 nM and smoothened agonist (Stemcell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 200nM ascorbic acid (STEMCELL Technologies), 500 μg/ml cyclic AMP (SIGMA) ...
-
bioRxiv - Biochemistry 2023Quote: ... and then enzymatically dissociated using 750 U/mL collagenase and 250 U/mL hyaluronidase (STEMCELL Technologies, 07912) and diluted in DMEM:F12 for 1.5 h ...
-
bioRxiv - Developmental Biology 2020Quote: ... Dispase II (2.5 U/mL; STEMCELL Technologies), fatty acid free bovine serum albumin (2% ...
-
bioRxiv - Microbiology 2022Quote: ... 0.5 U/mL Dispase II (StemCell Technologies), and 50 μg/mL DNase (Alfa Aesar ...
-
bioRxiv - Systems Biology 2022Quote: ... Dispase II (2.5 U/mL; STEMCELL Technologies), fatty acid-free bovine serum albumin (2% ...
-
bioRxiv - Cell Biology 2024Quote: ... and 3 U/mL heparin (StemCell Technologies) for differentiating progenitor cells into erythrocytes.
-
bioRxiv - Immunology 2024Quote: ... IFN-α (40,000 U/mL; STEMCELL Technologies), IL-2 (100 U/mL) ...
-
bioRxiv - Neuroscience 2021Quote: ... 200 nM ascorbic acid (StemCell Technologies), 1x penicillin streptomycin (ThermoFisher ...
-
bioRxiv - Pathology 2022Quote: ... 200 µM Ascorbic Acid (StemCell Technologies), and 1µM Dibutyryl-cAMP (StemCell Technologies).
-
bioRxiv - Immunology 2024Quote: ... FRT tissues were digested using collagenase type II (62.5 U/ml) and DNase I (0.083 U/ml) (STEMCELL Technologies). Cell suspensions were separated by Percoll (GE healthcare life sciences ...
-
bioRxiv - Neuroscience 2021Quote: Dispase (5 U/mL) (STEMCELL Technologies, Cat. 07913)
-
bioRxiv - Neuroscience 2021Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Immunology 2021Quote: ... and 0.1 U/ml dispase (STEMCELL Technologies, #07913) in DMEM supplemented with 10% FCS ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Immunology 2024Quote: ... and 5 U/ml dispase (#07913 STEMCELL Technologies) with mild agitation for 60 min in a water bath at 37°C ...
-
bioRxiv - Physiology 2024Quote: ... dispase II (2.5 U ml−1; Stemcell Technologies), and fatty acid-free BSA (2% ...
-
bioRxiv - Neuroscience 2021Quote: ... ascorbic acid (200 μM, #72132; StemCell Technologies), GDNF (20 ng/ml ...
-
Prevention of tau accumulation through inhibition of hnRNP R-dependent axonal Mapt mRNA localizationbioRxiv - Neuroscience 2023Quote: ... 1 µM retinoic acid (72264, Stemcell Technologies) was added to the medium ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.2 M ascorbic acid (STEMCELL Technologies).
-
bioRxiv - Neuroscience 2023Quote: ... non-essential amino acids (NEAA, Stemcell technologies). After 24h (day0) ...
-
bioRxiv - Biochemistry 2022Quote: ... 0.2 mM ascorbic acid (Stem cell technologies), 20ng/ml BDNF (Petrotech ...
-
bioRxiv - Developmental Biology 2024Quote: ... GABA and pipecolic acid (STEMCELL Technologies #05896). For routine cell maintenance ...
-
bioRxiv - Neuroscience 2024Quote: ... and ascorbic acid (200nM, STEMCELL Technologies, # 72132). Neurons were maintained on MEA plates with half-medium changes every third day until the experiment ...
-
bioRxiv - Neuroscience 2024Quote: ... 200 nM ascorbic acid (Stem Cell Technologies), 1 ng/mL TGFβ3 (Lonza) ...
-
bioRxiv - Genomics 2021Quote: ... and DNase I (0.3 U/mL (07900, STEMCELL Technologies)) and incubated 45 mins at 37 °C and further filtered through a 20 μm cell strainer (43-10020-40 ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1000 U recombinant human LIF (StemCell Technologies #78055). Medium was replaced daily ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 15 U/ml Dispase II (Stemcell Technologies, 7913) in HBSS) ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 15 U/ml Dispase II (Stemcell Technologies, 7913) in HBSS) ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 200 nM ascorbic acid (Stemcell Technologies,72132) till desired time ...
-
bioRxiv - Microbiology 2024Quote: ... and Am580 retinoic acid agonist (2.5μM; STEMCELL Technologies) at 0.8-1 × 106 cells/mL density ...
-
bioRxiv - Genetics 2022Quote: ... iPSCs were treated with 1 U/ml dispase (StemCell Technologies) and transferred to uncoated T-25 flasks in mTESR media supplemented with 10 μM ROCK inhibitor ...
-
bioRxiv - Cancer Biology 2024Quote: ... and resuspended in 5 U/mL dispase (StemCell Technologies, 07913) with 0.1 mg/mL DNase I (Sigma-Aldrich ...
-
bioRxiv - Cell Biology 2023Quote: ... followed by 5 U/ml dispase (Stem Cell Technologies, 07913) and 50 ug/ml DNase I (Sigma ...
-
bioRxiv - Immunology 2023Quote: ... Dissociation media contained 0.5 U/mL dispase (Stemcell Technologies, 07923), 0.1 mg/mL DNase I (Sigma-Aldrich ...
-
Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosisbioRxiv - Systems Biology 2021Quote: ... All-Trans Retinoic Acid 0.1 µM (RA; StemCell Technologies) and Purmorphamine 0.5 µM (PMN ...
-
bioRxiv - Neuroscience 2022Quote: ... 3.52 μg/mL Ascorbic acid (Stem cell technologies # 72132), 0.5mM L-glutamine and 1% NEAA and then plated on to T25 flasks ...
-
bioRxiv - Neuroscience 2022Quote: ... Ascorbic acid (200 nM, Cat. No. 72132 STEMCELL Technologies), and laminin (1 μg/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... and 200 nM Ascorbic Acid (#72132; Stem Cell Technology). From day 43 to 120 ...
-
bioRxiv - Cell Biology 2023Quote: ... and Am580 retinoic acid agonist 2.5 μM (STEMCELL Technologies) at 2 × 106 cells/mL density ...
-
bioRxiv - Molecular Biology 2022Quote: ... and 10 µM ascorbic acid (AA) (Stemcell Technologies 72132). Day 2 ...
-
bioRxiv - Physiology 2024Quote: ... and 0.1 μM all-trans retinoic acid (STEMCELL Technologies). Media was substituted daily until podocyte maturation on day 12 ...
-
bioRxiv - Bioengineering 2024Quote: ... 0.24 mM all-trans retinoic acid (Stem Cell Technologies), 0.5 mM PD173074 (Tocris ...
-
bioRxiv - Systems Biology 2024Quote: ... cells were dissociated with 2.5 U/ml Dispase (Stemcell Technology 07913), and re-plated as small clumps at ∼1:6 ratio onto a new MEF layer ...
-
bioRxiv - Cancer Biology 2022Quote: ... PHA was washed and IL-2 (50 U/ml, StemCell Technology) was added to the medium and replaced every 2 days for a time period of 5 days.
-
bioRxiv - Microbiology 2023Quote: ... ascorbic acid (50 μg/ml, STEMCELL Technologies, Cat# ST-72132), 1 × GlutaMAX (Thermo Fisher Scientific ...
-
bioRxiv - Developmental Biology 2024Quote: ... 0.5 μM 1-Oleoyl Lysophosphatidic Acid (LPA; STEMCELL Technologies, 72694), 10 ng/mL LIF ...
-
bioRxiv - Developmental Biology 2024Quote: ... and 1 μM valproic acid (VPA; HDACi; STEMCELL Technologies, 72292). After three days in this medium ...